The Canadian Independent

This clinical trial was Moderna’s First 2-dose trial of its mRNA-1273 Covid-19 vaccine conducted back in 2020.

One interesting part of Moderna’s mRNA-1273 Covid-19 vaccine clinical trial documents is the 218 pages dedicated to serious adverse events (SAEs) reported during follow up aBer the jabs. These pages categorize the participants into three groups: those who took placebo shots, those who took a placebo and then an mRNA shot, and those who solely took 2 doses of the mRNA shot.

In the placebo group, there were only 5 pages with 7 participants listed as having a serious adverse event. These are pages 2 to 6.

However, when examining the participants flagged for a serious adverse event in the placebo-mRNA jab or solely the 2 doses of the mRNA jab category, there are hundreds of pages with hundreds of participants. These are pages 7 to 208.

Image: Mufid Majnun @ Unsplash